Nanobiotix (NASDAQ:NBTX) Stock Price Down 2% – Here’s What Happened

Nanobiotix S.A. (NASDAQ:NBTX) fell 2% on Tuesday . The company traded as low as $3.75 and last traded at $3.95. 27,386 shares traded hands during trading, an increase of 61% from the average session volume of 17,058 shares. The stock had previously closed at $4.03.

Nanobiotix Trading Down 2.0 %

The company’s fifty day moving average price is $3.30 and its 200-day moving average price is $4.15.

Institutional Investors Weigh In On Nanobiotix

Several hedge funds have recently added to or reduced their stakes in the stock. Geode Capital Management LLC purchased a new position in shares of Nanobiotix in the 4th quarter worth about $29,000. Millennium Management LLC bought a new stake in Nanobiotix during the 4th quarter valued at about $39,000. Jane Street Group LLC purchased a new position in Nanobiotix in the fourth quarter worth about $73,000. Finally, OLD Mission Capital LLC bought a new position in shares of Nanobiotix in the fourth quarter worth approximately $139,000. 38.81% of the stock is owned by institutional investors.

Nanobiotix Company Profile

Nanobiotix SA, a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer.